نتائج البحث - "Maria Luisa Gomez-Dorronsoro"

1

دورية أكاديمية

PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification

المؤلفون: Pablo Azcue, Ignacio Encío, David Guerrero Setas, Javier Suarez Alecha, Arkaitz Galbete, María Mercado, Ruth Vera, Maria Luisa Gomez-Dorronsoro

المصدر: Cancers, Vol 13, Iss 8, p 1943 (2021)

مصطلحات موضوعية: PD-L1, CMS, colon cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6694/13/8/1943; https://doaj.org/toc/2072-6694

URL الوصول: https://doaj.org/article/c8428c35398b400c94ee58dce2813186

Find this article in full text from ProQuest

Full Text Finder

2

Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus

المصدر: Pancreatology. 21:215-223

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Cell Cycle Proteins, Neuroendocrine tumors, Capecitabine, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Cell Line, Tumor, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, In patient, Everolimus, DNA Modification Methylases, Domain family, Aged, Aged, 80 and over, Temozolomide, Hepatology, business.industry, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Gastroenterology, Nuclear Proteins, Middle Aged, Prognosis, medicine.disease, Immunohistochemistry, Survival Analysis, Progression-Free Survival, Pancreatic Neoplasms, Neuroendocrine Tumors, DNA Repair Enzymes, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, 030211 gastroenterology & hepatology, Neoplasm Recurrence, Local, business, Immunosuppressive Agents, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99446b736194f9226f1502ff56b16498
https://doi.org/10.1016/j.pan.2020.12.009

View record from ScienceDirect

Full Text via ClinicalKey

3

A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma

المؤلفون: Maria Luisa Gomez-Dorronsoro, Berta Ibáñez-Beroiz, Ruth Vera, María del Rosario Mercado, Pablo Azcue, Ignacio Encío, David Guerrero Setas

المساهمون: Universidad Pública de Navarra. Departamento de Ciencias de la Salud, Nafarroako Unibertsitate Publikoa. Osasun Zientziak Saila

المصدر: Cancers; Volume 13; Issue 23; Pages: 5909
Cancers
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Cancers, Vol 13, Iss 5909, p 5909 (2021)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d777bffd35a72d1b3d40d4da9b6e0843

Find this article in full text from ProQuest

4

PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification

المؤلفون: Ruth Vera, María del Rosario Mercado, Javier Suarez Alecha, Maria Luisa Gomez-Dorronsoro, Pablo Azcue, David Guerrero Setas, Arkaitz Galbete, Ignacio Encío

المساهمون: Universidad Pública de Navarra. Departamento de Ciencias de la Salud, Nafarroako Unibertsitate Publikoa. Osasun Zientziak Saila

المصدر: Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Cancers, Vol 13, Iss 1943, p 1943 (2021)
Cancers
Volume 13
Issue 8

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c314469cef6e1fcc9c549686c624ae
https://pubmed.ncbi.nlm.nih.gov/33920689

Find this article in full text from ProQuest

5

1167P SILVELUL SCORE: An original or modified immunohistochemical score (IPS or mIPS) in patients (pts) with pancreatic neuroendocrine tumours (PanNET) treated with everolimus or CAPTEM

المصدر: Annals of Oncology. 31:S775

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Everolimus, business.industry, Hematology, Neuroendocrine tumors, medicine.disease, Internal medicine, medicine, Immunohistochemistry, In patient, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3223d0f26db50a25a31db0fff2995e6b
https://doi.org/10.1016/j.annonc.2020.08.1380

6

GETNE-SILVELUL study: A new immunohistochemical score (SPI) in patients (pts) with pancreatic neuroendocrine tumors (PanNET) treated with everolimus or captem

المؤلفون: M. Benavent, Guillermo Crespo, Antonio Viudez, Jairo Pérez-Sanz, Alberto Carmona, Saioa Goñi, Maria Luisa Gomez-Dorronsoro, Carlos F. Lopez, Marta Llanos, Vicente Alonso, J. Hernando, Isabel Sevilla, Iranzu González-Borja, Ana De Jesus-Acosta, Irene Hernandez, Borja Lopez De San Vicente, Beatriz Roig García, Ana Custodio

المصدر: Journal of Clinical Oncology. 38:e16707-e16707

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Neuroendocrine tumors, medicine.disease, Internal medicine, medicine, Immunohistochemistry, In patient, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e8b5317c54a412205815a8efed6d0861
https://doi.org/10.1200/jco.2020.38.15_suppl.e16707

7

SILVELUL project: Immunohistochemical panel analyses as potential predictive and prognostic factors in pancreatic neuroendocrine tumours (PanNET) treated with CAPTEM or everolimus

المؤلفون: Imanol Arozarena, Maria Luisa Gomez-Dorronsoro, Saioa Goñi, M. Benavent, A. De Jesus-Acosta, V. Alonso, G. Crespo Herrero, V. Arrazubi Arrula, Marta Llanos, Ana Custodio, Marina Baretti, Iranzu González-Borja, B. López de San Vicente, C. López, R. Grandez, M.C. Riesco Martínez, A. Viudez, A. Carmona Bayonas, P. Jiménez-Fonseca

المصدر: Annals of Oncology. 30:v196

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Prognostic factor, Everolimus, Clinical variables, business.industry, O-6-methylguanine-DNA methyltransferase, Hematology, Prognostic score, Internal medicine, Distribution pattern, medicine, Immunohistochemistry, In patient, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2eb253312ce5f86bb38d4cab2f1cd79b
https://doi.org/10.1093/annonc/mdz245.006

8

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients

المساهمون: Instituto de Salud Carlos III, European Commission, Grupo Español de Investigación en Sarcomas, UAM. Departamento de Biología Molecular

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Oncotarget
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Biblos-e Archivo. Repositorio Institucional de la UAM
Digital.CSIC. Repositorio Institucional del CSIC

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb28de91e70eca5046f358fd09338255
http://hdl.handle.net/2445/178609

9

Correlation between RECIST-conventional imaging techniques, morphologic response by CT and histopathologic response, in hepatic metastasis secondary to colorectal cancer: The AVAMET study

المصدر: Journal of Clinical Oncology. 33:e14656-e14656

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Colorectal cancer, Morphologic Response, Retrospective cohort study, medicine.disease, Hepatic metastasis, humanities, Biologic Agents, Internal medicine, medicine, business, Histopathologic response, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cd2d3151cd6e2f1b743eb307a212262a
https://doi.org/10.1200/jco.2015.33.15_suppl.e14656

10

Is There Any Difference in Overall Response Rate According to Kras Mutation in Advanced Colorectal Cancer (Acrc)?

المؤلفون: Javier Suárez, Ruth Vera, Marta Montes, D. Guerrero, Angela Fernandez de Lascoiti, José Antonio Rivadeneira Cabana, Maria Luisa Gomez Dorronsoro, Miguel Angel Ciga Lozano, Irene Hernandez, Antonio Tarifa, Antonio Viudez, Juan Verdun

المصدر: Annals of Oncology. 24:iv117

مصطلحات موضوعية: Response rate (survey), Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, Colorectal cancer, medicine.medical_treatment, Hematology, medicine.disease, Advanced colorectal cancer, Overall response rate, Internal medicine, Mutation (genetic algorithm), Medicine, business, Kras mutation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35e97c2d0d28c3ac2ad940b4cd5943d
https://doi.org/10.1093/annonc/mdt203.288

تنقيح النتائج